Private Advisor Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$512K Sell
21,020
-40
-0.2% -$974 ﹤0.01% 1673
2025
Q1
$437K Sell
21,060
-1,393
-6% -$28.9K ﹤0.01% 1672
2024
Q4
$529K Sell
22,453
-4,790
-18% -$113K ﹤0.01% 1541
2024
Q3
$697K Sell
27,243
-16,614
-38% -$425K ﹤0.01% 1446
2024
Q2
$1.03M Sell
43,857
-4,329
-9% -$102K 0.01% 1190
2024
Q1
$1.39M Sell
48,186
-4,681
-9% -$135K 0.01% 997
2023
Q4
$1.73M Buy
52,867
+2,350
+5% +$77.1K 0.01% 833
2023
Q3
$1.41M Sell
50,517
-530
-1% -$14.8K 0.01% 865
2023
Q2
$1.74M Sell
51,047
-2,660
-5% -$90.7K 0.02% 780
2023
Q1
$1.62M Sell
53,707
-1,564
-3% -$47K 0.02% 782
2022
Q4
$1.56K Sell
55,271
-8,622
-13% -$243 ﹤0.01% 1155
2022
Q3
$2.1M Sell
63,893
-2,736
-4% -$89.9K 0.02% 606
2022
Q2
$2.1M Sell
66,629
-18,055
-21% -$569K 0.02% 735
2022
Q1
$3.89M Sell
84,684
-12,978
-13% -$596K 0.03% 539
2021
Q4
$5.98M Sell
97,662
-28,411
-23% -$1.74M 0.04% 395
2021
Q3
$9.42M Buy
126,073
+9,129
+8% +$682K 0.06% 320
2021
Q2
$10.8M Sell
116,944
-5,528
-5% -$511K 0.09% 220
2021
Q1
$10.9M Buy
122,472
+16,651
+16% +$1.48M 0.1% 195
2020
Q4
$9.87M Sell
105,821
-298
-0.3% -$27.8K 0.1% 204
2020
Q3
$6.62M Buy
106,119
+5,409
+5% +$338K 0.09% 235
2020
Q2
$5.25M Buy
100,710
+4,865
+5% +$254K 0.07% 254
2020
Q1
$3M Buy
95,845
+25,646
+37% +$802K 0.06% 315
2019
Q4
$2.35M Buy
70,199
+22,460
+47% +$753K 0.04% 476
2019
Q3
$1.41M Sell
47,739
-147
-0.3% -$4.34K 0.02% 643
2019
Q2
$1.65M Buy
47,886
+20,042
+72% +$691K 0.03% 539
2019
Q1
$916K Buy
27,844
+1,569
+6% +$51.6K 0.02% 702
2018
Q4
$630K Buy
26,275
+9,390
+56% +$225K 0.02% 749
2018
Q3
$564K Buy
+16,885
New +$564K 0.01% 939